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ABSTRACT
Background: In-utero exposure to mercury and other trace metals pose a significant 
threat to child health and development, but exposures and health impacts in artisanal 
and small-scale gold mining (ASGM) environments are poorly defined. 
Objectives: We describe the CONAMAD study design, a prospective birth cohort consisting 
of multiparous women (18 and over) living in rural and peri-urban Peruvian Amazon 
communities exposed to ASGM.
Methods: Pregnant women are enrolled from health posts across four zones of Madre 
de Dios, Peru. Data are collected at enrollment, childbirth, and (planned) 36-48 months. 
At enrollment, hair samples for mercury assessment, demographic and clinical data are 
obtained. At birth, we obtain venous and cord blood, placenta, hair, toenails, and saliva. 
Findings: Two hundred seventy mothers were enrolled at an average 20 weeks gestational 
age with no differences in maternal characteristics across zones. Two hundred fifteen 
mothers were successfully followed at birth. We obtained 214 maternal and cord blood 
samples, 211 maternal and 212 infant hair samples, 212 placenta samples, 210 infant 
saliva samples, and 214 infant dried blood spots. Data collected will allow for testing our 
primary hypotheses of maternal malnutrition modifying ratios of cord:maternal blood total 
mercury (tHg), cord blood:maternal hair tHg, and infant:maternal hair tHg, and whether 
chemical mixtures (Hg, Pb, Cd) have synergistic effects on infant neurodevelopment.
Conclusions: CONAMAD is designed to collect and store samples for future processing and 
hypothesis testing associated with in-utero mercury exposure and child development. We 
have completed the exposure assessments and will conduct a follow-up of mothers to 
evaluate early child development outcomes, including developmental delay and growth. 
These data offer insights into disease mechanisms, exposure prevention, and policy 
guidance for countries where ASGM is prevalent.
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I. INTRODUCTION 
Methylmercury (MeHg) exposure from dietary intake is likely to lead to detrimental internal doses 
in susceptible groups, particularly in developing fetuses due to its ability to cross the blood brain 
barrier [1, 2]. When entering the bloodstream, organic mercury (i.e., MeHg) binds to sulfhydryl 
groups and is distributed throughout the body. MeHg deposited into the brain can become 
trapped as it slowly demethylates to inorganic mercury that cannot penetrate the blood-brain 
barrier. The mechanism through which mercury induces neurotoxicity is not clear [3], but many 
have been proposed, including a glutathione pathway [4], glutamate excitotoxicity [5, 6], and 
mitochondria and reactive oxygen species [7, 8]. A key question is related to MeHg toxicity in-utero 
as higher levels of MeHg exposure may be experienced by fetuses compared to adults in similar 
environments, and equivalent levels of exposure may lead to greater negative health impacts for 
individuals exposed to high and/or chronic MeHg in-utero. Cord blood mercury levels are often 
higher than levels in maternal blood, perhaps due to higher levels of cord blood hemoglobin, 
which binds free MeHg, increasing active transport of mercury to the fetus [9–12] or decreasing 
clearance due to low levels of glutathione (GSH), which binds MeHg and targets it for removal [13]. 
In addition, the MeHg-cysteine complex is believed to mimic a crucial amino acid, methionine, 
which a developing fetus may preferentially absorb in the context of maternal undernutrition 
[14, 15]. Maternal malnutrition can exacerbate the impact of chemical exposures on pregnancy 
complications, such as gestational hypertension or preeclampsia, by increasing maternal MeHg 
absorption and subsequent mercury transport to the fetus. Alternatively, chemical exposure can 
impair nutrient absorption, such as protein synthesis or metabolism of zinc (Zn) and iron (Fe) [16]. 
Unfortunately, epidemiological studies to elucidate the relationship between malnutrition and 
MeHg are scant. 
Neurobehavioral and immune function can also be impaired from perinatal exposure to MeHg with 
other potentially toxic trace elements (lead [Pb], arsenic [As] and cadmium [Cd]), as compared to 
those exposed in adulthood [17], possibly due to dysregulation of the epigenome during critical 
periods of development. Regardless of these toxicological risks, impacts of MeHg and mixtures 
with MeHg have not been fully evaluated, especially in the context of other known risk factors 
for child health in a developing region like the Peruvian Amazon. Several studies conducted in the 
US have reported epigenome-wide alterations in infants exposed perinatally to mercury [18, 19], 
although the gestational window of greatest susceptibility is still unknown. Prior studies report 
epigenomic deregulation in offspring following maternal malnutrition at the time of conception, 
but not in the third trimester [20–22]. Few comparable studies have been conducted outside of the 
U.S., and none in Peru or in an artisanal and small-scale gold-mining (ASGM) region. 
In November 2016, we initiated a birth cohort to enable assessment of peri-conceptional, 
late gestation and early life stages as potential critical windows of developmental exposure 
to MeHg. The study is in Madre de Dios, Peru, a southwestern region of the Amazon (Figure 1). 
The population of Madre de Dios has high exposure incidence to dietary mercury due to ASGM-
related mercury pollution and consumption of high trophic level fish [23–25]. In addition, there is 
high prevalence of malnutrition among women of child-bearing age compared to other regions 
where developmental MeHg exposure effects were studied, such as in the Seychelles [26, 27] and 
Faroe Islands [28]. The study is named CONAMAD, or Cohorte de Nacimiento de Madre de Dios 
(Birth Cohort of Madre de Dios), which roughly translates as “with mothers” in Spanish. NIEHS 
(1R21ES026960) provided the primary funding for the design and data collection for this study. 
Funding for data collection was also provided by the Doris Duke Clinical International Research 
Fellowship and the Duke Center for Latin American and Caribbean Studies. Additional funding for 
data processing was provided by the NIEHS Superfund Research Program (P42ES010356) and the 
Josiah Charles Trent Memorial Foundation Endowment Fund (Grant #17-23). The 36–48-month 
follow-up is funded by the State University of New York-Albany. The study was motivated by 
the 2016 El Niño event for which we hypothesized that large-scale flooding from El Niño would 
increase mercury methylation and bioaccumulation, resulting in higher dietary mercury exposure. 
We specified three hypotheses: 
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(i). Internal MeHg dose of infants in utero as measured in cord blood samples will exceed 
internal doses as measured by maternal hair Hg levels and this relationship would be 
mediated by maternal nutrition; 
(ii). Poor maternal nutrition will correlate with a higher cord:maternal blood Hg ratio; and 
(iii). Exposure to chemical mixtures with MeHg in-utero (in mothers) will lead to greater than 
additive impacts on infant neurocognitive function via indirect (maternal exposure  
gestational hypertension  small for gestational age  cognitive deficits) and direct 
effects (infant exposure  cognitive deficits). 
Funding was used to maximize data collected from mothers and newborns and store the 
majority of data for future analysis. Data collected include: hair, toenails, blood and placenta 
for assessment of multi-panel trace elements exposure; clinical health outcomes (hypertension, 
small for gestational age, child growth, anemia, arbovirus exposure); saliva and dried blood spots 
(DBS) for epigenetic analysis from newborn and their siblings from the same biological parents 
(as a control); neurocognitive impairment (developmental delay); and socio-demographic 
and nutritional measures from survey data. Here we describe the study design, enrollment 
and birth characteristics of mother-child dyads, and initial findings from enrollment and birth 
data. 
II. COHORT DESCRIPTION
1. SETTING – MADRE DE DIOS
Madre de Dios (MDD) borders Brazil and Bolivia (Figure 1), and has the lowest population density 
in Peru (2017 estimated population 141,070, ~20% indigenous [29]) and one of the largest 
concentrations of biodiversity in the world, with four protected parks and ~15% of Peru’s forest 
areas [30]. Families living in MDD are involved in a variety of occupations: agriculture, fishing, 
logging, Brazil nut (castaña) collection, gold mining, construction, and tourism. Houses are 
modest, made of simple wood or concrete block construction with palm thatch or corrugated zinc 
roofs, and many lack indoor plumbing and access to electricity from a centralized power network 
Figure 1 CONAMAD Study Site 
and Enrollment Locations, 
Madre de Dios, Peru. 
Dotted lines represent 
estimated catchment area; 
large “+” symbols represent 
enrollment sites (health 
centers). ASGM is currently 
concentrated in the Colorado, 
Puquiri, Inambari and 
Malinowski rivers. Sample 
size obtained in each zone at 
enrollment and followed at 
birth: Zone 1, 43 enrolled, 37 
births; Zone 2, 67 enrolled, 50 
births; Zone 3, 147 enrolled, 
121 births; Zone 4, 13 enrolled, 
7 births.
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(note: most mothers living in Puerto Maldonado have running water and electricity). Medical care 
for the study region is available at the Regional Ministry of Health (DIRESA) health posts, which 
have variable quality and supplies to provide basic medical care. For serious or prolonged illnesses, 
patients are usually referred to a Centro de Salud or one of the two regional hospitals (Hospital San 
Martin de Porres in Iberia, Hospital Santa Rosa in Puerto Maldonado).
Like many regions around the world, MDD is undergoing rapid development. The construction of the 
Interoceanic Highway (IOH, completed in 2011) [31, 32] and expansion of ASGM over the past two 
decades, has driven urbanization, internal migration, deforestation, social conflicts and the emergence 
of dual burdens of disease [33–37]. ASGM is also the underlying cause for widespread MeHg exposure 
risk as it is related to rapid deforestation, environmental mercury (Hg) release, and biomagnification 
of MeHg in local fish species and food sources [24, 38–43]. Our team led the first population-
based assessment of mercury exposure in the region, estimating that 58% of the population live in 
communities affected by ASGM and 43% of women of child-bearing age (WCBA, 15–49 years) have 
hair mercury levels exceeding 2.2 ug/g, a level corresponding to the WHO provisional tolerable weekly 
intake [24], which was consistent with estimates from our study of mercury exposure of WCBA in 
native and non-native communities surrounding the Amarakaeri Reserve [44]. 
2. CHARACTERISTICS OF WOMEN OF CHILD-BEARING AGE AND PREGNANCY IN 
MADRE DE DIOS
In Peru, the Ministry of Health recommends a minimum of 6 antenatal care visits. Clinical care 
during a prenatal visit usually includes administration (or prescription) of iron tablets or syrup, 
medicine for intestinal parasites, maternal weight, blood pressure, blood sample (for anemia 
assessment), belly width, and neonatal tetanus shot, among others. Women usually give births 
in designated birthing clinics (in MDD: Hospital Santa Rosa and Centro de Salud Nuevo Milenio in 
Puerto Maldonado, and Hospital San Martin de Porres in Iberia). Other Centros de Salud can attend 
“imminent” births. If a woman arrives at a birthing clinic but is not near initiating labor, she must 
return home, stay with nearby family, or pay for subsidized housing, which tend to be in disrepair. 
Thus, it is not uncommon for women, with a controlled, normal pregnancy, to wait until the last 
minute for an “imminent” delivery that can be attended in her local health facility.
We leveraged two two-stage cluster samples to design the birth cohort: the 2014 Encuesta 
Demografica y de Salud Familiar (ENDES, Demographic and Health Survey [45]); and our team’s 
2014 Interoceanic Highway Study (Investigacion de Migracion, Ambiente y Salud or IMAS) [24, 46]. 
ENDES sampled 138 households, 112 WCBA and included Puerto Maldonado; IMAS sampled 310 
households, 232 WCBA and excluded Puerto Maldonado. 
ENDES and IMAS exhibited agreement for most indicators of interest. The total fertility rate was 
approximately 3 births per woman, 12% of WCBA were married (~55% in a consensual union), and 
WCBA received between 8 and 9 years of schooling. Anemia prevalence among WCBA was 29.1% in 
ENDES versus 43% in IMAS (identical methods used). Surveys reported WCBA with similar prevalence 
of short stature (<145 cm, 8–11%), an indicator of increased risk for adverse maternal and child 
health outcomes, and for prevalence of overweight or obese (body mass index or BMI > 25), which 
was 66% of WCBA. Both surveys indicated high prenatal and childbirth health care utilization, with 
93% of pregnant women from both surveys reporting at least 4 prenatal care visits with the median 
gestational age of the first visit occurring at three months. Overall, 96% of women from ENDES and 
87% from IMAS who gave birth in the five years prior to the survey did so in a health clinic or hospital, 
and 97% (ENDES) and 87% (IMAS) of births were attended by a health professional (doctor, nurse, or 
obstetrician). Additional data in ENDES not reported in IMAS included maternal report of underweight 
at birth (under 2500 grams, 4.3%), very small size at birth (1.5%) and smaller size than average at 
birth (21%). Both surveys indicated an approximate stunting prevalence around 10% in children under 
five; however, ENDES reported 51% of children under five are anemic, while IMAS estimated 70%. 
2. STUDY DESIGN 
CONAMAD is a prospective birth cohort to measure in-utero (fetal) mercury exposure in pregnant 
mothers and the impact of exposure on newborn health and development. Human subjects research 
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approval is through the Universidad Peruana Cayetano-Heredia (UPCH) Comité Institucional de Ética 
(CIE) para Humanos (SIDISI 66471), the DIRESA Madre de Dios, and the Duke University Office of 
Research Support via an Inter-Institutional Agreement with UPCH. Follow-up was further approved 
by the University at Albany Offices of Research Support via Inter-Institutional Agreements with UPCH.
Enrollment occurred in four zones across MDD to capture pregnant women living in four general 
categories of environmental mercury exposure (Figure 1): (1) Huepetuhe vicinity, representing older 
and larger gold mining areas; (2) La Pampa vicinity, representing more recent and emerging gold 
mining; (3) the Puerto Maldonado urban and sub-urban vicinity; and (4) Iberia vicinity, representing 
non-ASGM impacted communities. These four categories were defined from prior data [24, 41, 42] 
and we expected, a priori, that mercury exposure would be highest in zones 1 and 2, moderate in 
zone 3 and low in zone 4. We note that the highest concentration of indigenous communities is in 
zone 1; however, no indigenous mothers were enrolled.
The study design involves prenatal enrollment and data collection at birth and 36–48 months of 
age post-partum, with each contact point involving targeted data collection (Figure 2). Pregnant 
women were enrolled during any trimester prior to 30 weeks gestation. To be eligible, pregnant 
woman met the following criteria: (1) primary residence in MDD; (2) aged 18–30 years old; 
(3) reside with a domestic partner or spouse; and (4) have at least one additional child from the 
same biological parents as the unborn fetus (a child from the same set of parents as a potential 
control in epigenetic analysis). Exclusion criteria were: (1) clinical diagnosis of type II diabetes 
before pregnancy; (2) current smoker; (3) residence outside of MDD for more than two weeks 
during pregnancy (assessed at the time of enrollment); and (4) planning to give birth outside 
of MDD. Women were invited to participate by study nurses and health professionals at each 
of the regional hospitals/birth centers or by fieldworkers in close communication with medical 
personnel. If they agreed to participate, eligibility was ascertained and, if eligible, the interviewer 
would either review the consent form with the mother or she could review the form herself. If a 
woman could not read or could not speak Spanish, we provided local translation for her. Consent 
included approval for individual chemical exposure results to be shared with the local DIRESA 
and long-term storage of their biological samples for future testing. Once consent was obtained, 
clinical records of consenting women were stamped to increase the likelihood that a fieldworker 
would be notified and present at the time of birth. An enrollment survey was administered, a hair 
sample was obtained to measure prenatal mercury exposure, and a subset of women were given 
a silicone wristband to wear for seven days to measure exposure to volatile organic compounds 
(VOCs) and polycyclic aromatic hydrocarbons (PAHs). The enrollment survey includes transcription 
of prenatal care clinical records, including weight, blood pressure, and supplements administered, 
diet (frequency of fish consumption by species), and prenatal complications. Previous work in the 
region by our team on diet helped inform food consumption questions [23, 46].
Figure 2 CONAMAD Study 
Design Overview and timing of 
data collection. 
The SARS-COV-2 has delayed 
the 24-month follow-up by at 
least 12 months; thus, we will 
initiate follow-up in January 
2022.
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At birth, data collected include: a postnatal survey; maternal and newborn hair samples, newborn 
toenails, and maternal and cord blood for trace elements exposure assessment (focusing primarily 
on Hg); placenta; and dried blood spots (DBS) and saliva samples for epigenetic testing (the DBS 
is also obtained for arbovirus screening). Fieldworkers were able to travel to most birthing centers 
within an hour, except for Iberia, which is four hours from Puerto Maldonado. Medical personnel at 
each hospital/birthing center were trained on how to take blood, placenta, hair, and nail samples, in 
case the fieldworker was not present. Three tufts of hair, from the mother and newborn (if possible) 
were obtained from the occipital region of the scalp. The hair specimens were cut with stainless 
steel scissors, secured on self-adhesive note paper with the proximal end fixed in the adhesive part 
of the paper, and placed in plastic zip lock bags with 2–3 silica gel desiccants. Newborn toenails, if 
possible, were collected using baby clippers and placed in paper envelope bags. Two 6 ml tubes of 
maternal blood were obtained using BD Vacutainer® Trace Element Plastic Blood Collection Tubes 
(with EDTA). Four 6 ml tubes of cord blood were similarly obtained by drawing blood from the 
already cut umbilical cord after birth. Four placenta punch biopsies were obtained (one punch from 
each of the four quadrants of the placenta) and stored in cryovials filled with AllProtect® tissue 
reagent as a stabilizer. Cord blood and placenta samples were obtained in a separate room from 
the mother to avoid contamination. Saliva was obtained from the newborn using a saliva sponge 
tip. Dried blood spots from the mother and infant (via heel stick) were obtained using Whatman 
cards and hemoglobin levels for anemia were evaluated.
Biomarkers we plan to process include total hair Hg, total blood Hg, and other trace elements 
for maternal and cord blood samples. Banked (stored) samples include: placenta, saliva, DBS, 
bracelets for VOCs and PAHs. Duplicate and triplicate samples of hair, and blood will also be used 
for future stable isotope analysis, epigenetic testing, and cortisol. 
We initiated a 24-month follow-up in December 2019 with child ages expected to range from 
20–33 months, with most visits occurring at approximately 24 months of age. This follow-up was 
halted due to COVID-19 with plans to re-start the study by January 2022. Data are planned to be 
collected from the child (newborn), the child’s parents, sibling, and, if present in the household or 
living nearby, maternal grandparents (Figure 2). Anthropometrics, a DBS, and a hemoglobin test will 
be obtained from all individuals (hemoglobin testing only for the mother, child, and sibling). Hair and 
toenail samples are obtained from the child and their parents and sibling. Saliva is obtained from 
the child (if not obtained at birth) and sibling. Blood pressure is obtained from adults (parents and 
grandparents). Finally, the child will be administered the Ages and Stages Questionnaire (ASQ-3) to 
screen for developmental delays or disorders (validated up to 60 months) [47], which has been used 
in many contexts, including in Peru [48–50]. Children identified at risk of developmental delay in one 
of the five areas evaluated in the ASQ-3 will be referred to the Madre de Dios office of community 
mental health. The follow-up survey includes data on household composition, (individual) dietary 
consumption (including primary food that is shared with the family and secondary food consumed 
only by the individual), infant breastfeeding practices, occupation, migration/travel, access to 
markets and health care, parental stress and parenting, and social vulnerability. 
CONAMAD is designed to achieve 80% power with 250 mother-child dyads at the 0.05 significance 
level to detect a 20% increase in the Hgc:Hgm (c = cord blood; m = maternal blood equivalent 
from hair) in mothers pregnant during El Niño or whose infants were born having low birthweight 
compared to mothers pregnant after El Niño (i.e., this assumed a non-El Niño exposure ratio of 
1.25 and a 20% loss to follow-up). Unfortunately, funding and IRB approval were not obtained until 
October 2016, after the El Niño event. Therefore, we re-computed power to detect an increase in the 
Hgc:Hgm ratio for malnourished mothers compared to non-malnourished mothers, as measured 
by short stature and/or anemia during pregnancy. Research indicates that iron deficiency, a cause 
of anemia, can increase maternal absorption of Hg [51]. In addition, research has estimated a 20–
30% increase in absorption of MeHg for fetal erythrocytes compared to maternal erythrocytes [52, 
53]. Therefore, we hypothesize that anemic mothers to have a minimum 20% higher Hgc:Hgm 
compared to non-anemic mothers, which is the same power calculation as estimated above. Note 
that a 30% increase in the Hgc:Hgm ratio (consistent with potential increased MeHg in fetal blood 
from anemia mothers) would have 97% power and, at this effect size, a Bonferroni adjustment 
with three comparisons still achieves more than 93% power. 
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3. SAMPLE CHARACTERISTICS AT ENROLLMENT
Two hundred seventy pregnant women were enrolled between November 2016 and July 2018 
in 12 health posts across the four zones. In 2017, MDD recorded a total of 4137 births [54]; thus, 
our sample represents approximately 4.4% of all births during the period of study or 7% of births 
over a one-year period. Just over half of the women were enrolled from zone 3 (surrounding 
Puerto Maldonado); 41% from zones 1 or 2 (Huepetuhe and La Pampa area, respectively); and 
5% from non-ASGM impacted communities (Table 1). Women were regularly enrolled over time 
(Supplemental Figure 1). The average gestational age of enrollment was 20 weeks (Table 1), and 
there were no differences in enrollment timing by zone with 21% of women enrolled during their 
first trimester, 53% in their second, and 26% in their third (Table 1). Other characteristics of mothers 
at enrollment did not vary significantly by zone, including median maternal age (28 years) and 
prevalence of short stature (16.6%), with highest prevalence of short stature in mining areas (zones 
1 and 2). Median age of male partners was 30 years and most women lived in a consensual union 
(94%). The most common forms of employment were driving a taxi (19%), farming (16%) and 
mining (14%). Other types of employment included construction (9%), machine operation and 
mechanic (8%), and administrative work (7%). We did not record the place of birth for the mother 
at enrollment; however, for their male partners, 39% were born in Madre de Dios and 35% in Cusco. 
Overall, 48% of male partners were born in an Amazon region of Peru and 48% in the highlands. 















Median Age, years (mean) 27 (26.9) 28 
(27.6)
28 (27.4) 25.5 
(25.3)
28 (27.3) 0.2532











Enrolled in … 1st Trimester 
(<14 weeks)
27.9% 19.4% 19.1% 38.5% 21.5% 0.1995
 … 2nd Trimester (14–26 
weeks)
39.5% 50.8% 57.8% 53.9% 53.0%
 … 3rd Trimester (>26 weeks) 32.6% 30.0% 23.1% 7.7% 25.6%
% Short Stature, ht ≤ 1.45 m 23.30% 20.90% 12.90% 15.40% 16.60% 0.2953






30 (30.7) 28 (29.0) 30 (31.1) 0.1859
Mother lives near1
 … gold shops 25.6% 20.3% 7.9% 8.3% 13.6% 0.0098
 … mining 53.9% 20.3% 7.9% 0.0% 17.7% <0.0001
 … gas station 56.4% 20.3% 37.9% 8.3% 35.2% 0.0050
 … road near vehicle traffic 74.4% 25.4% 58.6% 16.7% 51.2% <0.0001
 … trash burning 71.8% 35.6% 37.9% 8.3% 41.2% 0.0007
 … farms that burn before 
planting
51.3% 23.7% 18.0% 50.0% 26.1% <0.0001
Mother takes the following 
supplements1
 … Folic Acid 84.2% 96.7% 77.7% 80.0% 83.7% 0.0111
 … Iron 41.7% 93.6% 35.5% 57.1% 51.6% <0.0001
 … Ferrous Sulfate 79.3% 83.9% 76.0% 62.5% 77.4% 0.5889
 … Any above supplements 90.5% 96.9% 86.7% 91.7% 90.1% 0.1537
Table 1 CONAMAD Enrollment 
characteristics.
Health posts by zone: 
Zone 1-Mazuko, Primavera Baja, 
Santa Rosa; Zone 2-Laberinto, 
Alto Libertad; Zone 3-El Triunfo, 
Nuevo Milenio, Jorge Chavez, 
La Joya, Pueblo Viejo; Hospital 
Santa Rosa; Zone 4-Hospital 
San Martin de Porres (Iberia).
1 Maternal residence and 
nutritional supplements have 
the following sample sizes in 
each zone: 39, 59, 140, and 12 
for zones 1–4, respectively.
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4. DATA MANAGEMENT AND ANALYSIS
Surveys and biomarkers were stored in a secure office (and freezer) in the Instituto de Investigaciones 
de la Amazonia Peruana (IIAP) near Puerto Maldonado prior to shipment to our laboratory at Duke 
University. For each woman, we created a unique ID consisting of the two-digit year of enrollment, 
two-digit initials of the enrolling health post, two-digit month of enrollment, and two-digit number 
representing the n-th mother enrolled during that month. This code will identify the maternal family, 
with the mother assigned the letter A, newborn B, spouse/partner C and so on. All biomarkers (e.g., 
hair, blood, placenta, etc.) are recorded with the name of the participant and their unique ID. 
A secure ACCESS database was created for enrollment, birth and follow-up survey data. 20% of 
surveys were screened for data entry errors and if error detection exceeded 10%, all surveys were 
screened. ACCESS data at enrollment and birth were exported and variables recoded for future 
analysis in SAS V9.4, R or STATA. 
Trace element analyses were performed on hair and blood samples in the Hsu-Kim laboratory at 
Duke University using similar protocols are previously described [15, 33, 42]. Briefly, the proximal 
2-cm length of hair was cut, weighed, and analyzed for total Hg content by thermal decomposition, 
amalgamation, atomic absorption spectrometry (Milestone DMA-80). The instrument was 
calibrated using diluted mixtures of a certified standard solution of 1 mg L–1 Hg2+ dissolved in 5% 
HNO3 (Brooks Rand). At the start of each batch run, the instrument calibration was confirmed 
with analysis of a standard reference material (SRM) hair samples (ERM DB001 Hg: 0.365 mg/kg) 
and verification of measured value within the certified concentration value. Analyses of analytical 
blanks and the SRM as repeated every 10 samples to verify instrument performance.
The concentrations of Hg and other trace elements (Cr, Mn, Fe, Cu, Zn, As, Se, Cd, Pb) were 
quantified in whole blood samples by inductively coupled plasma mass spectrometry (ICP-MS) 
(Agilent Technologies 7900). First, a 0.5 mL aliquot of a thawed blood sample was transferred to 
pre-cleaned polypropylene test tubes and digested with 1 mL of ultra-trace clean nitric acid (70%, 
SCP Science) and 0.05 ml of ultra-trace clean hydrochloric acid (35%, SCP science) for two hours 
at 65°C. After two hours, the samples were allowed to cool and 1 ml of ultra-trace clean hydrogen 
peroxide was added (30%, SCP Science) to the mixture. The blood was digested for an additional 
hour. After the digestions, the samples were cooled and spiked with 10 microliters of a 4 mg L–1 
gold solution preserved in 5% HCl. Prior to ICP-MS analysis, the samples were diluted with a 2% 
HNO3/0.5% HCl (v/v) diluent. The diluent included internal standards at a 20 µg L
–1 concentration 
(45Sc, 89Y, 103Rh, 115In, 159Tb, 193Ir, 197Au, and 209Bi). All elements were analyzed in helium reaction 
gas mode, except for Se and Fe which were analyzed in hydrogen mode. An aliquot of caprine 
blood SRM (NIST SRM933c: levels 2, 3, or 4) was analyzed in parallel with each sample batch of 
24. Additionally, for each batch of 24 samples, two blood samples were selected and digested in 
triplicate. The ICP-MS instrument was calibrated and tuned daily at the start of each batch run. 
Calibrations were verified by an aqueous SRM (High Purity Standards: CRM-TMDW-A). Instrument 
blanks and calibration checks were performed at least once per 30 samples in the batch run.
Results from metals analysis will be compared against measures of newborn development, 
including APGAR score, anemia (measured clinically at birth and every post-natal follow-up), birth 
weight and size, two-year growth (clinically measured at each post-natal follow-up), and cognitive 
development (via the ASQ-3). 
III. FINDINGS TO DATE, CHARACTERISTICS OF WOMEN FOLLOWED 
AT BIRTH
Of the 270 pregnant mothers enrolled, we successfully followed up 215 (80%) mothers at childbirth 
(Table 2). One of these 215 mothers had twins and an additional enrolled mother had a stillbirth. 
Among these women, we obtained 214 maternal and cord blood samples, 211 maternal and 212 
infant hair samples, 212 placenta samples, 210 saliva samples, and 214 DBS. Lab processing of 
trace element contents for blood samples are complete; analysis of hair samples is ongoing. All 
other samples are stored for future use in a -80C freezer at Duke. 
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Median age of women was 28 years, similar to enrollment. Malnutrition prevalence was high, with 
70% of women classified as anemic at the time of childbirth (hemoglobin under 12 g/dL) and 
11% of short stature. Anemia was high across all zones, while short stature was more prevalent 
in zones 2 and 4. The total number of prenatal care visits was highest in zone 2 (7.9 visits) and 
lowest in zone 3 (6.9 visits). Hypertension prevalence during pregnancy was low overall (6% of 
pregnancies) but exceeded 8% in zones 1 and 2. Overall prevalence of cesarean births was 18%, 
but 11.7% were emergency cesareans and occurred primarily in zone 1. 
There were 55 women lost to birth follow-up. Of these, 28 (51%) were lost due to their failure 
to notify the study team when the birth was occurring. Another 14 (25%) gave birth in another 
location (Cusco, Lima, etc.). The remaining lost to follow-up include two mothers who had an 
abortion and 11 with variable reasons such as lacking cell phones to call the study team, nervous 
about the study, or had a rapid labor such that they delivered at home or somewhere outside the 
health post. These women lost to follow-up did not significantly differ from those followed up by 
maternal age, zone, gestational age at enrollment, or stature. However, women not followed at 
birth had significantly fewer prior pregnancies compared to those who were followed (2.6 vs. 3.3, 
p = 0.0013). All women are being re-contacted for follow-up regardless of whether birth data were 
collected.
Characteristics of the newborn are important indicators for impacts of in-utero exposure as well 
as indicators of early development during the first two years of life. We use several indicators 
to determine fetal growth outcomes. First, we use World Health Organization definitions for 
preterm births in three categories based on gestational age (Extremely preterm, <28 weeks; Very 
preterm, 28 to <32 weeks; Late preterm, 32 to <37 weeks) [55]. Second, in the clinic, health care 
professionals estimated small for gestational size using standard protocols. Finally, we use the 
standard cutoff of 2500 g at birth as low birthweight. Additional measurements at birth include 
1-minute and 5-minute APGAR scores. 
Of the 216 children enrolled, 55.6% were male, which was relatively consistent across zones 
(Table 3). The average gestational age was 39 weeks, with only 5% of births occurring preterm. 
Similarly, 5% of children were classified as small-for-gestational age and 2% were born under 
2500 g. APGAR scores were normal for almost all children. A surprising result was the large size of 
newborns: 35% were considered large gestational age and 56% were over 3500 g at birth. None 
of these birth outcomes varied by zone of enrollment (Table 3). 
Table 2 Characteristics of 
Mothers Followed at Birth.
Health posts by zone: 
Zone 1-Mazuko, Primavera Baja, 
Santa Rosa; Zone 2-Laberinto, 
Alto Libertad; Zone 3-El Triunfo, 
Nuevo Milenio, Jorge Chavez, 
La Joya, Pueblo Viejo; Hospital 
Santa Rosa; Zone 4-Hospital 
San Martin de Porres (Iberia).
2 No women were classified 
as having severe anemia 
(Hb < 7.0). Hb level reported 
is from the last prenatal visit, 
sample sizes by zone are: 37, 
48, 120, 6.
3 Short Stature sample sizes by 
zone are: 36, 50, 120, and 5.
4 Hypertension during 
pregnancy sample sizes by 
zone are: 36, 49, 115, 7.
5 Emergency cesarean has a 
sample size in zone 1 of 36.




BY ZONE1 2 3 4
N (%) 37 (17%) 50 (23%) 121 (56%) 7 (3%) 215
Median Age, years (mean) 27 (27.2) 27.5 (27.8) 28 (27.7) 23 (23.9) 28 (27.6) 0.1033
Hemoglobin (Hb) Level2      
  … Moderate Anemia  
(Hb 7.0–9.9)
5.4% 4.2% 9.2% 0.0% 7.1% 0.9041
  … Anemia (Hb 10.0-11.9) 62.2% 66.7% 61.7% 66.7% 63.0%
 … Normal (Hb ≥ 12) 32.4% 29.2% 29.2% 33.3% 29.9%
Short Stature, % ht ≤ 1.45m3 11.1% 22.0% 6.7% 20.0% 11.4% 0.0350
Total Prenatal Visits 7.5 (2.1) 7.9 (1.8) 6.9 (2.2) 7.4 (2.4) 7.2 (2.10) 0.0253
Hypertension during 
pregnancy, percent4
8.3% 8.2% 5.2% 0.0% 6.3% 0.7428
Emergency Cesarean5 19.4% 8.0% 11.6% 0.0% 11.7% 0.2973
Birth attendant ….. Physician 18.9% 20.0% 17.4% 28.6% 18.6% 0.7858
 …. Obstetrician 78.4% 78.0% 77.7% 57.2% 77.2%
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IV. Strengths and Limitations
This unique birth cohort measures in-utero metals exposure of mother-child dyads in an ASGM 
region where there is a high prevalence of anemia and malnutrition, yet low prevalence of low 
birthweight and small for gestational age. In other seminal birth cohorts, sample sizes are larger, 
and they are typically conducted in developed or urbanized regions where women have access 
to high quality prenatal care. The high prevalence of malnutrition in our sample allows for the 
evaluation whether these disorders alter the toxicological paradigm for defining levels of risk when 
such populations are exposed to toxic trace metals, including risk for developmental toxicity.
In addition, our unique sample benefits from high motivation of mothers to remain connected 
to the study, aiding our ability to conduct the 36–48 month follow-up and enables construction 
of risk profiles for infants born to WCBA living in ASGM regions. Thanks to our community and 
individual engagement, mothers remain steadfast in their support with less than 1% of mothers 
communicating any reservations about participation. This support has resulted in our ability to 
maximize biomarker collection even for samples that mothers know they may not learn of results 
for years to come due to funding constraints. 
Another major strength of this study is the extensive collection of biomarkers (toxicological 
exposure assessment), clinical and health outcomes (growth, cognition, epigenetics), and socio-
demographic data that enable cross-cutting analyses of environmental factors impacting human 
health. This is of primary interest to local and regional health and environmental agencies, with 
whom we have fostered a strong partnership. DIRESA- Madre de Dios has provided access to clinical 
records as well as helped inform physicians and nurses of our study. The high rate of post-natal 
visitation has also enabled the use of in-depth clinical data on the children regarding vaccination 
dates, anthropometry, illnesses, medications, and nutritional supplements, among others. 
One potential limitation of this study is the relatively small sample size compared to birth cohorts 
in the Seychelles and Faroe Islands. However, as noted earlier, our enrollment sample of 270 
mothers represents between 4.4% and 7% of all births in the region. In addition, our sample size 
of 215 mother-child dyads still allows us to test our major hypotheses and it is possible for us 
to augment the sample using the same protocols if additional data are needed for future tests. 




BY ZONE1 2 3 4
N (%) 37 (17%) 51 (24%) 121 (56%) 7 (3%) 216
Male, % 51.1% 68.3% 51.2% 57.1% 55.6% 0.194
Gestational age at birth, 
weeks (SD)1
39.1 (2.13) 39.3 (1.41) 38.8 (3.40) 39.0 (1.87) 39.0 
(2.82)
0.7613
Gestation: % born 
before 37 weeks1
2.8% 8.5% 4.1% 11.1% 5.3% 0.4575
Size for gestational age 
(clinical)
     0.4072
 …. Small 2.7% 3.9% 5.8% 0.0% 4.6%
 …. Large 32.40% 35.30% 38.00% 0 35.20%
Birth weight2      0.1677
 …. <2500 g 0.0% 2.0% 2.5% 0.0% 1.9%
 …. 2500–3000 13.9% 5.9% 9.1% 9.0% 8.8%
 …. 3000–3500 36.1% 27.5% 31.4% 85.7% 33.0%  
 …. >3500 50.0% 64.7% 67.0% 14.3% 56.3%
APGAR < 7, 1 minute2 0.0% 3.9% 2.5% 0.0% 2.3% 0.6575
APGAR < 7, 5 minutes 0.0% 2.0% 1.0% 0.0% 1.0% 0.8000
Table 3 Characteristics of 
Newborns.
Health posts by zone: 
Zone 1-Mazuko, Primavera Baja, 
Santa Rosa; Zone 2-Laberinto, 
Alto Libertad; Zone 3-El Triunfo, 
Nuevo Milenio, Jorge Chavez, 
La Joya, Pueblo Viejo; Hospital 
Santa Rosa; Zone 4-Hospital 
San Martin de Porres (Iberia).
1 Gestational age at birth has 
the following sample sizes, 
respectively by zone: 36, 46, 
120, 7.
2 Birthweight and APGAR score 
sample sizes by zone: 36, 47, 
120, 7.
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Another potential limitation in our study is the low prevalence of low birthweight (2%) and small 
for gestational age (5%) compared to 4.3% and 1.2% reported from ENDES, respectively. It is 
possible that, given our engagement with mothers, risk for low birthweight decreased, but we 
expect differences in our clinical definition of these outcomes vs. maternal recall in ENDES. 
Another limitation of our study is the delay in the original 24-month follow-up due to COVID-19. 
The study design will remain unchanged when we restart; however, we may suffer from loss of 
participants due to migration or death. 
V. COLLABORATION
We welcome collaborations with other researchers. We have a collaborative research team 
consisting of experts in environmental science, toxicology, epidemiology, biostatistics, and clinical 
research. Researchers interested in collaborating can visit our website for more information (https://
sites.globalhealth.duke.edu/panlab/) and email the PI, William Pan (William.pan@duke.edu). 
ADDITIONAL FILE
The additional file for this article can be found as follows:
•	 Supplemental Figure 1. CONAMAD Mother’s Date of Enrollment and Expected Date of Birth 
at the time of enrollment. DOI: https://doi.org/10.5334/aogh.3152.s1
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